S
BIIB icon

Seeyond’s Biogen BIIB Stock Holding History

Seeyond’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.46M Sell
8,900
-16,311
-65% -$4.61M 0.24% 137
2022
Q3 		$6.73M Buy
25,211
+15,321
+155% +$3.25M 0.81% 13
2022
Q2 		$2.02M Buy
9,890
+9,283
+1,529% +$1.9M 0.23% 131
2022
Q1 		$127K Buy
607
+49
+9% +$10.7K 0.01% 571
2021
Q4 		$133K Buy
558
+503
+915% +$129K 0.01% 578
2021
Q3 		$15K Sell
55
-7,752
-99% -$2.54M ﹤0.01% 601
2021
Q2 		$2.7M Buy
7,807
+1,451
+23% +$440K 0.25% 99
2021
Q1 		$1.78M Sell
6,356
-3,054
-32% -$824K 0.18% 189
2020
Q4 		$2.3M Buy
9,410
+2,007
+27% +$518K 0.24% 120
2020
Q3 		$2.1M Sell
7,403
-262
-3% -$73.1K 0.23% 116
2020
Q2 		$2.05M Buy
7,665
+4,618
+152% +$1.39M 0.23% 113
2020
Q1 		$545K Buy
3,047
+451
+17% +$137K 0.08% 358
2019
Q4 		$770K Sell
2,596
-1,267
-33% -$352K 0.08% 388
2019
Q3 		$899K Buy
3,863
+954
+33% +$222K 0.09% 339
2019
Q2 		$680K Sell
2,909
-1,357
-32% -$313K 0.07% 405
2019
Q1 		$1.01M Buy
4,266
+2,351
+123% +$740K 0.1% 315
2018
Q4 		$576K Buy
+1,915
New +$611K 0.08% 346

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Seeyond's BIIB Position: Q4 2022 in Review

Seeyond reduced its Biogen (BIIB) stake by 65% in Q4 2022, selling an estimated $4.61M and leaving 8,900 shares worth $2.46M. The position accounts for 0.24% of the portfolio, ranked #137.

Seeyond first reported a position in BIIB in Q4 2018 and has held it in 17 quarters since. The position peaked at $6.73M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Seeyond held 8,900 shares of Biogen worth $2.46M as of Q4 2022.
  • Seeyond sold 16,311 Biogen shares in Q4 2022, an estimated $4.61M.
  • Biogen made up 0.24% of Seeyond's portfolio in Q4 2022, its #137 holding.
  • Seeyond first reported a position in Biogen in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Biogen position peaked at $6.73M in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.